Goldman Sachs Group Inc Cara Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $555 Billion
  • Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 51,643 shares of CARA stock, worth $33,567. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,643
Previous 209,872 75.39%
Holding current value
$33,567
Previous $155,000 70.32%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.52 - $1.05 $82,279 - $166,140
-158,229 Reduced 75.39%
51,643 $46,000
Q4 2023

Feb 13, 2024
BUY
$0.6 - $1.65 $45,005 - $123,764
75,009 Added 55.62%
209,872 $155,000
Q3 2023

May 14, 2024
SELL
$1.67 - $3.33 $125,265 - $249,779
-75,009 Reduced 35.74%
134,863 $226,000
Q3 2023

Nov 14, 2023
SELL
$1.67 - $3.33 $252,149 - $502,790
-150,988 Reduced 52.82%
134,863 $226,000
Q2 2023

May 14, 2024
SELL
$2.83 - $4.94 $50,300 - $87,803
-17,774 Reduced 5.85%
285,851 $808,000
Q2 2023

Aug 14, 2023
SELL
$2.83 - $4.94 $50,300 - $87,803
-17,774 Reduced 5.85%
285,851 $808,000
Q1 2023

May 14, 2024
BUY
$4.89 - $12.27 $39,584 - $99,325
8,095 Added 2.74%
303,625 $1.49 Million
Q1 2023

May 11, 2023
BUY
$4.89 - $12.27 $39,584 - $99,325
8,095 Added 2.74%
303,625 $1.49 Million
Q4 2022

May 14, 2024
BUY
$8.88 - $12.77 $264,508 - $380,379
29,787 Added 11.21%
295,530 $3.17 Million
Q4 2022

Feb 13, 2023
BUY
$8.88 - $12.77 $264,508 - $380,379
29,787 Added 11.21%
295,530 $3.17 Million
Q3 2022

May 14, 2024
BUY
$8.24 - $12.56 $992,153 - $1.51 Million
120,407 Added 82.85%
265,743 $2.49 Million
Q3 2022

Nov 10, 2022
BUY
$8.24 - $12.56 $992,153 - $1.51 Million
120,407 Added 82.85%
265,743 $2.49 Million
Q2 2022

May 14, 2024
SELL
$7.45 - $13.84 $480,793 - $893,178
-64,536 Reduced 30.75%
145,336 $1.33 Million
Q2 2022

Aug 15, 2022
BUY
$7.45 - $13.84 $129,548 - $240,663
17,389 Added 13.59%
145,336 $1.33 Million
Q1 2022

May 16, 2022
BUY
$9.94 - $12.65 $18,886 - $24,035
1,900 Added 1.51%
127,947 $1.56 Million
Q4 2021

Feb 14, 2022
SELL
$11.99 - $18.14 $2.17 Million - $3.28 Million
-180,961 Reduced 58.94%
126,047 $1.54 Million
Q3 2021

Nov 10, 2021
BUY
$11.55 - $16.06 $3.55 Million - $4.93 Million
307,008 New
307,008 $4.74 Million

Others Institutions Holding CARA

# of Institutions
101
Shares Held
21.5M
Call Options Held
50K
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $34.9M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email